Ganna Stupnytska, Nataliya Gorovenko, Svetlana Podolska, Zoriana Kit, Michael Sheremet, Anatoliy Kovtun, Olga Nesterovska


Introduction: Attention has been paid to studying the role of the sympathetic nervous system and polymorphism of the β2-adrenoceptor genes in the development of chronic obstructive pulmonary disease (COPD) in recent years, but the findings of the studies contradict each other.

Objective:  To establish an association between the ADRB2 gene polymorphic variant C79G (rs1072714) in obese and non-obese COPD patients.

Methods: The study involved 48 obese COPD patients and 52 nonobese COPD patients. The ADRB2 gene polymorphic variant C79G (rs1072714) was genotyped and assessed by the CAT test and the BODE index.

Results: It has been established that in obese COPD patients the CAT test was significantly higher in the genotype GG (24.25 ± 4.25) compared to those with obesity and the genotype CC and CG (p <0.05). The BODE index was significantly (p <0.05) lower in obese COPD patients. A strong positive correlation between BMI and FEV1 (r = 0.742, p = 0.014) in nonobese COPD patients with GG genotype has been found.

Conclusion:  According to the CAT test, the quality of life in obese COPD patients with GG genotype is worse. The BODE index in obese COPD patients with CC and CG genotypes was significantly lower than in those without obesity. A strong positive correlation between BMI and FEV1 in COPD patients without obesity with GG genotype has been established.


chronic obstructive pulmonary disease, obese, BODE, CAT

Full Text:



Abston, E., Comellas, A., Reed, R., Kim, V., Wise, R., Brower, R., Fortis, S., Beichel, R., Bhatt, S., Zabner, J., Newell, J., Hoffman, E., Eberlein, M. (2017). Higher BMI is associated with higher expiratory airflow normalized for lung volume (FEF25-75/FVC) in COPD. BMJ open Respiratory Research, 4, 000231. doi: 10.1136/bmjresp-2017-000231.

Aplalasamy, Y., Ming, M., Rampal, S., Bulgiba, A., Mohamed, Z. (2015). Gender-dependent association of a β(2)-adrenergic gene variant with obesity parameters in Malaysian Malays. Asia Pacific Journal of Public Health, 27(2), NP154-165. doi: 10.1177/1010539511430250.

ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories: ATS statement guidelines for the six-minute walk test. (2002). American Journal Respiratory Critical Care Medicine, 66, 111-117.

Barnes, P., Celli, B. (2009). Systemic manifestations and comorbidities of COPD. European Respiratory Journal, 33 (5), 1165-1185.

Blum, A., Simsolo, C., Sirchan, R., Haiek, S. (2011). “Obesity paradox” in chronic obstructive pulmonary disease. Israel Medical Association Journal, 13(11), 672-675.

Cecere, L., Littman, A., Slatore, C. (2011). Obesity and COPD: associated symptoms, health-related quality of life, and medication use], including increased prevalence and severity of asthma. COPD, 8, 275-284.

Celli, B., Cote, C., Lareau, S., Meek, P. (2008). Predictors of survival in COPD: more than just the FEV1. Journal of Respiratory Medicine, 102(1), S27-35.

Celli, B., Cote, C., Marin, J., Casanova, C., Montes de Osa, M., Mendez, R., Plata, V., Cabral, H. (2004). The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. The New England Journal of Medicine, 350, 1005-1012.

Corlateanu, A., Botnaru, V., Covantev, S., Dumitru, S., Siafakas, N. (2016)/ Predicting health-related quality of life in patients with chronic obstructive pulmonary disease: the impact of age. Respiration, 92, 229-234. doi: 10.1159/000448625.

Cote, C., Celli, B. (2009). BODE index: a new tool to stage and monitor progression of chronic obstructive pulmonary disease. Pneumonologia Alergologia Polska, 77, 305-313.

Franssen, F., O’Donnell, D., Goossens, G., Blaak, E., Schols, A. (2008). Obesity and the lung: 5 Obesity and COPD. Thorax, 63, 1110-1117. doi: 10.1136/thx.2007.086827.

Garcia-Sidro, P., Naval, E., Rivera, C., Bonnin-Vilaplana, M., Garcia-Rivero, J., Herrejon, A., Malo de Molina, R., Marcos, P., Mayoralas-Alises, S., Ros, J., Valle, M., Esquinas, C., Barrecheguren, M., Miravitlles, M. (2015). The CAT (COPD Assessment test) questionnaire as a predictor of the evolution of severe COPD exacerbations. Respiratory Medicine, 109(12), 1546-1552. doi: 10.1016/j.rmed.2015.10.011.

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2018 report) / 2018 Global Initiative for Chronic Obstructive Lung Disease, Inc. Retrieved from

Gorovenko, N., Stupnytska, G., Podolska, S. (2014). Polymorphic variants of ADRB2, NR3C1, VDR1 genes as possible predictors of efficacy of combined therapy LABA+ICS in patients with chronic obstructive pulmonary disease. The Pharma Innovation Journal, №3(8), 10-14.

Gorovenko, N., Stupnytska, G., Podolska, S. (2015). Polymorphic variants of genes ADRB2, NR3C1, MDR1 in patients with chronic obstructive pulmonary disease and obesity. European Respiratory Journal, 46(59), PA1232.

Gupta, N., Pinto, L., Benedetti, A., Li, P., Tan, W., Aaron, S., Chapman, K., FitzGerald, M., Hernandez, P., Marciniuk, D., Maltais, F., O’Donnell, D., Sin, D., Walker, B., Bourbeau, J. (2016). The COPD Assessment test. Chest, 150(95), 1069-1079.

Hallin, R., Gudmundsson, G., Ulrik, C. (2007). Nutritional status and long-term mortality in hospitalized patients with chronic obstructive pulmonary disease (COPD). Respiratory Medicine, 101, 1954-1960.

Hancock, D., Eijgelsheim, M., Wilk, J., Gharib, S., Loehr, L. (2010). Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nature Genetics, 42, 45–52.

Issac, M., Ashur, W., Mousa, H. (2014). Genetic Polymorphisms of Surfactant Protein D rs2243639, Interleukin (IL)-1β rs16944 and IL-1RN rs2234663 in Chronic Obstructive Pulmonary Disease, Healthy Smokers, and Non-Smokers [Abstract]. Molecular Diagnosis & Therapy, 18(3), 343-354. doi: 10.1007/s40291-014-0084-5.

Katz, P., Iribarren, C., Sanchez, G., Blanc, P. (2016). Obesity and functioning among individuals with chronic obstructive pulmonary disease (COPD). COPD, 13(3), 352-359.

Kavoura, P., Kostikas, K., Tselebis, A., Bratis, D., Kosmas, E., Alchanatis, M., Koulouris, N., Bakakos, P., Loukides, S. (2016). Changes in BODE quartiles after pulmonary rehabilitation do not predict 2-year survival in patients with COPD. Journal of Cardiopulmonary rehabilitation and preventation, 36(1), 62-67. doi:10.1097/HCR.0000000000000157.

Kim, W., Hersh, C., DeMeo, D., Reilly, J., Silverman, E. (2009). Genetic association analysis of COPD candidate genes with bronchodilator responsiveness. Respiratory Medicine, 103, 552-557,

Koniska, M., Salhi, H., Lahlou, A., Rashid, N., Hasnaoui, A. (2015). Distribution of body mass index among subjects with COPD in the Middle East and North Africa region: data from the BREATHE study. International Journal of COPD, 10, 1685-1694.

Konno, S., Makita, H., Hasegawa, M., Nusuhara, Y., Nagai, K., Betsuyaku, T. (2011). Beta2-adrenergic receptor polymorphisms as a determinant of preferential bronchodilator responses to β2-agonist and anticholinergic agents in Japanese patients with chronic obstructive pulmonary disease. Pharmacogenet. Genomics, 21, 687-693,

Lambert, A., Putcha, N., Drummond, M., Boriek, A., Hanania, N., Kim, V., Kinney, G., McDonald, M., Brigham, E., Wise, R., McCormack, M., Hanse. N. (2017). Obesity Is Associated With Increased Morbidity in Moderate to Severe COPD. Chest, 151(1), 68-77.

Landbo, C., Prescott, E., Lange, P. (1999). Prognostic value of nutritional status in chronic obstructive pulmonary disease. American Journal Respiratory Critical Care Medicine, 160, 1856-1861.

Leonska-Duniec, A., Ahmetov, I., Zmijewski, P. (2016). Genetic variants influencing effectiveness of exercise training programmes in obesity – an overview of human studies. Biology of Sport, 33(3). 207-214. doi: 10.5604/20831862.1201052.

Lopez-Campos, J., Fernandez-Villar, A., Calero-Acuna, C., Represas-Represas, C., Lopez-Ramirez, C., Fernandez, V., Soler-Cataluna, J., Casamor, R. (2015). Evaluation of the COPD assessment test and GOLD patient types: a cross-sectional analysis. International Journal of COPD, 10, 975-984.

Martinez, F., Graves, P., Baldini, M., Solomon, S., Erickson, R. (1997). Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing. Journal Clinical Investigation, 100(12), 3184-3188.

Melo, L., Silva, M., Calles, A. (2014). Obesity and lung function: a systematic review. Einstein (Sao Paulo), 21(1), 120-125., Zammit, C., Liddicoat, H., Moonsie, I., Makker, H. (2010). Obesity and respiratory diseases. International Journal of General Medicine, 3, 335-343.

Mokry, M., Joppa, P., Slaba, E., Zidzik, J., Habalova, V., Kluchova, Z., (2008). Beta2-adrenergic receptor haplotype and bronchodilator response to salbutamol in patients with acute exacerbation of COPD. Medical Science Monitor, 14, CR392-C398.

Nakato, A., Galhardo, M., Nakato, D., Ramires, B., Faganello, M. (2016). Pulmonary rehabilitation and BODE index in patients with COPD. SM Journal of Pulmonary Medicine, 2(2), 1018

Nielson, A., Jensen, C., Arredouani, M., Dahl, R., Dahl, M. (2017). Variants of the ADRB2 Gene in COPD: Systematic Review and Meta-Analyses of Disease Risk and Treatment Response. COPD, 14(4), 451-460. doi: 10.1080/15412555.2017.1320370.

Ong, K., Earnest, A., Lu, S. (2005). A multidimensional grading system (BODE index) as predictor of hospitalization for COPD. Chest, 128, 3810-3816.

Randhawa, I., Pham, A., Klaustermeyer, W., Yusin, J. (2014). No Correlation between Beta2-Adrenergic Receptor Polymorphisms and the Severity and Clinical Control of Geriatric Asthma and COPD. Journal of Allergy & Therapy, 5, 196. This article is available from: doi: 10.4172/2155-6121.1000196.

Saliba, L., Reis, R., Brownson, R., Hino, A., Tureck, L., Valko, C., Souza R., Furtado-Alle, L. (2014). Obesity-related gene ADRB2, ADRB3 and GHRL polymorphisms and the response to a weight loss diet intervention in adult women. Genetics and Molecular Biology, 37, 15-22.

Srivastava, A., Tripathi, S., Srivatsava, M., Kumar, V. (2017). To study the correlation between spirometry and CAT score in patients of COPD. Journal Evolution Medical Dental Science, 6(20). 1636-1638. doi:10.14260/Jemds/1017/358.

Thomsen, M., Nodestgaard, B., Sethi, A., Tybjarg-Hansen, A., Dahl, M. (2012). β2-adrenergic receptor polymorphisms, asthma and COPD: two large population-based studies. European Respiratory Journal, 39, 558-566. doi:10.1183/09031936.00023511/.

van den Borst, B., Koster, A., Yu, B. (2011). Is age-related decline in lean mass and physical function accelerated by obstructive lung disease or smoking? Thorax, 66, 961-969.

Vozoris, N., O’Donnell, D. (2012). Prevalence, risk factors, activity limitation and health care utilization of an obese, population-based sample with chronic obstructive pulmonary disease. Canadian Respiratory Journal, 19, e18-e24.

Zhang, H., Wu, J., Yu, L. (2014). Association of Gln27Glu and Arg16Gly polymorphisms in beta2-adrenergic receptor gene with obesity susceptibility: a meta-analysis. PLOS ONE, 9(6), e100489. doi: 10.1371/journal.pone.0100489.



  • There are currently no refbacks.

Print ISSN 1805-997X, Online ISSN 1805-9961

(c) 2018 CBU Research Institute s.r.o.

For more information on the conference visit